218 related articles for article (PubMed ID: 34558567)
1. A mitochondrion-targeted BODIPY-Ir(III) conjugate as a photoinduced ROS generator for the oxidative destruction of triple-negative breast cancer cells.
Qiao L; Liu J; Kuang S; Liao X; Kou J; Ji L; Chao H
Dalton Trans; 2021 Oct; 50(40):14332-14341. PubMed ID: 34558567
[TBL] [Abstract][Full Text] [Related]
2. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.
Bhattacharyya A; Jameei A; Karande AA; Chakravarty AR
Eur J Med Chem; 2021 Aug; 220():113438. PubMed ID: 33915370
[TBL] [Abstract][Full Text] [Related]
3. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
4. LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate.
Sarkar T; Bhattacharyya A; Banerjee S; Hussain A
Chem Commun (Camb); 2020 Jul; 56(57):7981-7984. PubMed ID: 32538387
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeting BODIPY-loaded micelles as novel class of photosensitizer for photodynamic therapy.
Li M; Li X; Cao Z; Wu Y; Chen JA; Gao J; Wang Z; Guo W; Gu X
Eur J Med Chem; 2018 Sep; 157():599-609. PubMed ID: 30125721
[TBL] [Abstract][Full Text] [Related]
6. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
8. Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity.
Raza MK; Gautam S; Garai A; Mitra K; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Sep; 56(18):11019-11029. PubMed ID: 28846407
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
10. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
11. Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "Chemo-PDT" Agent Active in Red Light.
Ramu V; Kundu P; Kondaiah P; Chakravarty AR
Inorg Chem; 2021 May; 60(9):6410-6420. PubMed ID: 33843212
[TBL] [Abstract][Full Text] [Related]
12. Oxoplatin-B, a cisplatin-based platinum(IV) complex with photoactive BODIPY for mitochondria specific "chemo-PDT" activity.
Bera A; Gautam S; Raza MK; Kondaiah P; Chakravarty AR
J Inorg Biochem; 2021 Oct; 223():111526. PubMed ID: 34246120
[TBL] [Abstract][Full Text] [Related]
13. BODIPY-Tagged Platinum(II) Curcumin Complexes for Endoplasmic Reticulum-Targeted Red Light PDT.
Upadhyay A; Kundu P; Ramu V; Kondaiah P; Chakravarty AR
Inorg Chem; 2022 Jan; 61(3):1335-1348. PubMed ID: 34990135
[TBL] [Abstract][Full Text] [Related]
14. Glucose-Appended Platinum(II)-BODIPY Conjugates for Targeted Photodynamic Therapy in Red Light.
Ramu V; Gautam S; Garai A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Feb; 57(4):1717-1726. PubMed ID: 29400953
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Effects of Ir(III)-2
Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
[TBL] [Abstract][Full Text] [Related]
16. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q
Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
18. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
19. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
20. BODIPY-based monofunctional Pt (II) complexes for specific photocytotoxicity against cancer cells.
Qi F; Yuan H; Chen Y; Guo Y; Zhang S; Liu Z; He W; Guo Z
J Inorg Biochem; 2021 May; 218():111394. PubMed ID: 33647541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
